Posts Tagged: inflammatory bowel disease

The Feinstein Institute and Applied Immunotherapeutics, Inc. Agree to Develop New Anti-Inflammatory Treatments for Autoimmune Disease


License agreement will commercialize breakthrough discoveries from the Feinstein Institute and Sweden’s Karolinska Institutet MANHASSET, NY – The Feinstein Institute for Medical Research at Northwell Health announced that it has agreed to license the rights to breakthrough discoveries in treating inflammation, as well as specific antibodies and drug candidates, to Applied Immunotherapeutics, Inc., a new business… read more

posted in: Press Releases tags: